Mitchell R. Humphreys, MD, Author at Grand Rounds in Urology

Mitchell R. Humphreys, MD

Mayo Clinic

Phoenix, Arizona

Mitchell R. Humphreys, MD, is Chair of the Department of Urology at the Mayo Clinic in Phoenix, Arizona. Dr. Humphreys’ clinical focus is on surgical and metabolic stone disease, benign prostatic hyperplasia (with a special focus on HoLEP), and minimally invasive genitourinary oncology. His research interests include urological malignancies and benign diseases; innovative, minimally invasive surgical procedures; and technology to improve treatments and outcomes.

Dr. Humphreys earned his medical degree at the University of Missouri in Columbia, Missouri. He then completed an internship in General Surgery and served as Chief Resident in Urology at the Mayo Clinic in Rochester, Minnesota. Dr. Humphreys subsequently completed a fellowship in Laparoscopic Endourology and Stone Disease at Indiana University in Indianapolis.

Dr. Humphreys has authored over 190 publications in his field and has been recognized for his work, being awarded the Best Manuscripts of the Year (2017) by the Journal of Urology. He has also been recognized by the American Urological Association, being awarded the Choosing Wisely Champion Award and Best Poster for Partial Prostatectomy, Demonstration of a Partial Prostatectomy, and HoLEP after Urolift (2016). Dr. Humphreys also serves as the Scientific Chair of the 42nd WCET Endourological Society.

Talks by Mitchell R. Humphreys, MD

The King of Enucleations: HoLEP

Mitchell R. Humphreys, MD | Feb 2025

Mitchell R. Humphreys, MD, MPH, delves into benign prostatic hyperplasia management and holmium laser enucleation (HoLEP).

Treating BPH: Comparing HoLEP, Rezūm, UroLift, and Aquablation

Mitchell R. Humphreys, MD | Dec 2019

Mitchell R. Humphreys, MD, reviews the current society recommendations addressing when to intervene with surgical management in patients with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). He provides an overview of new minimally-invasive surgical therapy technologies for these patients.

Updates in LUTS: Treating Overactive Bladder and Nocturia

Mitchell R. Humphreys, MD | Dec 2019

Mitchell R. Humphreys, MD, describes the shifting landscape of lower urinary tract symptoms (LUTS) management from a symptom-focused approach to a paradigm of altering the underlying disease progression. He focuses on changes in the medical management of nocturia and bladder outlet obstruction due to benign prostatic hyperplasia (BPH).